coccidioidomyosis database of 1541 patients from 2003 to 2014 was used. Cases were defined as patients who underwent bronchoscopy and had either positive serology {Immunodiffusion IgM (IDIgM) or IgG (IDIgG) with Complement Fixation titers (CF) at Kern County Public Health Lab.} or had microbiological or histopathological evidence of coccidioidomycosis. Epi Info 7 was utilized for statistical analysis.
Results. 98 cases met the criteria. 71 (72%) cases were male. 37 (38%) had diabetes. Most common presenting symptoms were cough 64% (n = 63) followed by fever 39% (n = 38). Out of 88 cases who had Chest CT-Scan 34% had cavitary lesions. Simple chest x-ray was positive for cavitation in 19% of patients (n = 19). Female patients had increased risk of having cavitary lesions in their chest x-ray; {OR: 5.2(1.8-16) P = 0.002}.
Spherules were found only in 7% of sputum samples (3/40) compare to 17% from bronchoscopy samples (16/91); P = 0.2. Cultures were positive in 21% of sputum samples (10/47) compare to 74% of samples from bronchoscopy (47/63) P < 0.001. In 22 cases (22%) initial serology was only positive for IDIgG and in 7 (7%) cases all initial serology markers were negative. Patients with positive cultures from any source had increased chance of having CF titers of 8 or higher {OR: 3.3 (1.1-10), P = 0.03}.
Direct visualization during bronchoscopy showed 65% presence of mild or moderate bronchitis; 22% presence of mucosal or sub mucosal nodule or lesions. Bronchoscopy samples were positive for presence of endosporulating spherules in 22 cases (22%).
Conclusion. Bronchoscopy is a valuable diagnostic tool in definitive diagnosis of pulmonary coccidioidomycosis.
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